Alpha Stem Cell Clinic

Section 1

Current Clinical Trials
Non-viral precision T cell receptor replacement for personalized cell therapy
New Infusion Center


The Alpha Stem Cell Clinic (ASCC) provides a centralized infrastructure from which to work with UCI faculty and staff to enhance stem cell clinical research and activities at UCI. The UCLA-UCI Alpha Stem Cell Clinic:

  • Is part of the California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic network
  • Promotes and facilitates scientific collaborations and interactions
  • Provides centralized clinical research infrastructure support
  • Accelerates the implementation of clinical research trials

CIRM Alpha Stem Cell Clinics: Collaboratively Addressing Regenerative Medicine Challenges »

Stem Cell

Clinical Trials


UCI tests cell therapy for myasthenia gravis

UCI Health and the UCI Alpha Clinic are conducting a clinical trial of an investigational cell therapy in patients with generalized myasthenia gravis, a rare autoimmune disorder.

UCI opens first natural killer cell clinical trial for recurrent glioblastoma

UCI Health and the UCI Alpha Clinic have opened the first clinical trial to assess the safety and effectiveness of CYNK-001, a natural killer cell therapy, in patients with recurrent glioblastoma (GBM), the deadliest form of brain cancer.


Location & Contact

UCI Alpha Stem Cell Clinic

Gross Hall: A CIRM Institute

University of California, Irvine
845 Health Sciences Road
1001 Gross Hall
Irvine, CA 92697-1705

Phone: (949) 824-3990